Revenue Cycle Management

U.S. healthcare changed considerably over the last decade, transitioning into a more technologically advanced and regulated industry. Some of the most notable drivers include increasingly more stringent regulations like President Obama’s Patient Protection and Affordable Care Act (ACA), more detailed coding systems, and evolving valued-based reimbursement and payment models.

Although these changes present challenges and increased costs for healthcare providers, they also create sizeable business opportunities for the outsourced business services (OBS) sector, particularly companies specializing in revenue cycle management (RCM). RCM is an integral outsourced service for healthcare providers because of changes in legislation and regulation, administrative operations, and consumer demographics.

Overall, the RCM industry is a relatively young segment of the OBS sector that developed over the past few decades as a result of the evolving, and expanding, U.S. healthcare market. Before that, healthcare providers were primarily small-town physicians who treated neighbors and friends for unstructured costs, and were sometimes only paid if patients recovered. Between the 1980s and 1990s, large IT management companies began deploying systems designed to help clients more effectively manage their transaction processing, billing and receivables management needs as the RCM industry slowly gained recognition and traction within the healthcare industry.

The RCM industry changed drastically since its inception when it only handled billing and collections, and basic administrative functions. Today, healthcare is a technologically advanced market that requires expertise in treating medical problems and handling administrative functions through sophisticated billing and payment processing networks, and electronic health record systems.

In 2015, the RCM industry produced about $18 billion in revenue, and is projected to grow to more than $26 billion in annual revenue by 2021 at a compounded annual growth rate of 5.5 percent.

As a result of the ongoing evolution of the healthcare industry, the RCM industry continues to grow and attract interest from financial and strategic buyers. Kaulkin Ginsberg has worked with a number of these companies over the years, serving as both a strategic and transaction advisor to board-level executives.

We understand the history of the RCM industry, continue to garner expertise within it, and have the foresight to know where the industry is heading. We are excited about the potential within the RCM industry and look forward to working with owners and executives who are committed to achieving their growth and exit objectives.

If you are interested in receiving a copy of The Healthcare Revenue Cycle Management Industry Overview, or if you would like to confidentially discuss your interests in the RCM industry, please contact a member of our strategic advisory team at hq@kaulkin.com.

 

 

LATEST BLOGS

The American Health Care Act: Potential Effects on ARM

March 20, 2017

Seven years after former President Barack Obama signed his signature bill, The Patient Protection and Affordable Care Act (ACA), there may actually be a repeal and replacement bill, hopefully fixing some of the problems incurred through the ACA. However, It's not clear whether this new bill will correct all of the problems associated with the ACA without creating a few new problems of its own. ....

» see this post    » all posts


Semiannual Employment Outlook for Q4 2016: Continued Optimism

March 17, 2017

Kaulkin Ginsberg's market intelligence team is optimistic about the current U.S. employment environment, specifically as it relates to the ARM industry. Overall, we believe the data suggests a significant increases in consumer spending will take place that will eventually drive debt accumulation throughout the economy, and thereby increasing revenue potential for the ARM industry.....

» see this post    » all posts


Will a Reduction in the Fed's Mortgage-Bond Holdings Impact Enterprise Business Valuations?

March 8, 2017

Since the Great Recession, key interest rates have been artificially low due to the Fed's QE plan, but as the Fed begins to sell MBS on the open market and decreases the size of its balance sheet, interest rates are expected to increase above and beyond changes in the federal funds rate. Without a doubt, this will have a significant impact on the U.S. economy, the ARM industry, and enterprise business valuations in 2017 and beyond.....

» see this post    » all posts


RECENT ANNOUNCEMENTS

ACA of Texas Publishes "Three Critical Healthcare Industry Trends for Outsourced Business Services" in its Winter 2017 Magazine

March 16, 2017

The ACA of Texas Publishes "Three Critical Healthcare Industry Trends for Outsourced Business Services" by Kaulkin Ginsberg in its Winter 2017 Magazine. Kaulkin Ginsberg details its belief that the growth in patient lending and financing programs, clinical integration networks, and physician quality reporting systems for the Centers for Medicare and Medicaid Services (CMS) could have profound effects on companies focused on servicing healthcare providers in 2017 and beyond.....

» see more




ACA of Texas Publishes "M&A Trends in the U.S. ARM Industry" in its Winter 2017 Magazine

March 15, 2017

The ACA of Texas Publishe "M&A Trends in the U.S. ARM Industry" an article by Kaulkin Ginsberg in its Winter 2017 Magazine. This article examines the key trends and developments driving M&A activity in the U.S. ARM industry by market segment.....

» see more




Mike Ginsberg Leading Panel Discussion at DBA International 20th Anniversary Conference

February 1, 2017

Mike Ginsberg, President and CEO of Kaulkin Ginsberg, will be speaking in a panel discussion on Trends in Debt Buying on Wednesday, February 8th at the DBA International 20th Anniversary Conference in Las Vegas, Nevada....

» see more